Long Qt Syndrome 5

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Balasubramaniam, Richard: 1 article (01/2007)
2.	Goddard, Catharine A: 1 article (01/2007)
3.	Grace, Andrew A: 1 article (01/2007)
4.	Gurung, Iman S: 1 article (01/2007)
5.	Hakim, Parvez: 1 article (01/2007)
6.	Huang, Christopher L-H: 1 article (01/2007)
7.	Killeen, Matthew J: 1 article (01/2007)
8.	Thomas, Glyn: 1 article (01/2007)

Drugs and Important Biological Agents (IBA) related to Long Qt Syndrome 5:

1.	Proteins (Proteins, Gene)FDA Link 01/01/2007 - "Mutations within KCNE1 encoding a transmembrane protein which coassembles with K+ channels mediating slow K+, I(Ks), currents are implicated in cardiac action potential prolongation and ventricular arrhythmogenicity in long QT syndrome 5. We demonstrate the following potentially arrhythmogenic features in simultaneously recorded, left ventricular, endocardial and epicardial monophasic action potentials from Langendorff-perfused murine KCNE1-/- hearts for the first time. "
2.	Potassium Chloride FDA LinkGeneric 01/01/2007 - "Mutations within KCNE1 encoding a transmembrane protein which coassembles with K+ channels mediating slow K+, I(Ks), currents are implicated in cardiac action potential prolongation and ventricular arrhythmogenicity in long QT syndrome 5. We demonstrate the following potentially arrhythmogenic features in simultaneously recorded, left ventricular, endocardial and epicardial monophasic action potentials from Langendorff-perfused murine KCNE1-/- hearts for the first time. "